Complete dosing information for evolocumab
Medical guidance required: Dosing information here is for educational purposes. Your healthcare provider will determine the appropriate dose based on your specific condition, kidney function, other medications, and medical history. Never adjust your dose without consulting your doctor or pharmacist.
Primary hyperlipidemia/CV risk reduction: 140 mg SC every 2 weeks OR 420 mg SC once monthly. Homozygous FH: 420 mg SC once monthly (may increase to every 2 weeks if inadequate response).